Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction

Clinical trial NCT02474199 · COMPLETED

Trial details

NCT number: NCT02474199
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Liver Transplant Recipient Living Donor (of the Respective Liver Transplant Recipient)

Start date: 2016-06-06
Primary completion: 2019-12-16
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.